Antimicrobial activity of RU-66647, a new ketolide

Diagnostic Microbiology and Infectious Disease

Volumn 27, Issue 1-2, 1997, Pages 7-12

  Jones, Ronald N ^a,b   Biedenbach, Douglas J ^a  

^a UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

^b UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; CLINDAMYCIN; ERYTHROMYCIN; HMR 3004; KETOLIDE; OXACILLIN; TELITHROMYCIN; UNCLASSIFIED DRUG; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIMICROBIAL ACTIVITY; ARTICLE; CONTROLLED STUDY; HAEMOPHILUS; MINIMUM INHIBITORY CONCENTRATION; MORAXELLA; NEISSERIA; NONHUMAN; PRIORITY JOURNAL;

ANTI-BACTERIAL AGENTS; AZITHROMYCIN; BACTERIA, ANAEROBIC; CLINDAMYCIN; DRUG RESISTANCE, MICROBIAL; ERYTHROMYCIN; GRAM-NEGATIVE BACTERIA; GRAM-POSITIVE BACTERIA; KETOLIDES; MACROLIDES; MICROBIAL SENSITIVITY TESTS; PENICILLIN RESISTANCE; STAPHYLOCOCCUS; STREPTOCOCCUS; VIRGINIAMYCIN;

EID: 0030887438     PISSN: 07328893     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0732-8893(96)00181-2     Document Type: Article

References (16)

1. Agouridas C, Beneditti Y, Bonnefoy A, Collette P, Denis A, Mauvais P, Labbe G, Chantot JF (1996) Ketolides: A new class of macrolide antibacterials. Structural characteristics and biological properties of RU 004. In Program and Abstracts of the 3rd International Conference on the Macrolides, Azalides, and Streptogramins, Lisbon, Portugal, abst 14.10, p. 97.
2. Agouridas C, Bonnefoy A, Chantot JF (1995a) In vitro antibacterial activity of RU 004, a novel ketolide highly active against respiratory pathogens. In Program and Abstracts of the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy. Washington, DC: American Society for Microbiology, abst F158, p. 140.
3. Agouridas C, Bonnefoy A, Chantot JF (1995b) In vivo antibacterial activity of RU 004, a novel ketolide highly active against respiratory pathogens. In Program and Abstracts of the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy. Washington, DC: American Society for Microbiology, abst F171, p. 143.
4. Agouridas C, Collette P, Mauvais P, Chantot JF (1995c) RU 004: Preliminary studies on the mechanism of action. In Program and Abstracts of the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy. Washington, DC: American Society for Microbiology, abst F170, p. 142.
5. Centers for Disease Control and Prevention (CDC) (1996) Defining the public health impact of drug-resistant Streptococcus pneumoniae: Report of a working group. MMWR 45:1-14.
6. Cormican MG, Jones RN (1996) Emerging resistance to antimicrobial agents in Gram-positive bacteria. Drugs 51(suppl):6-12.
7. Dabernat H, Seguy M, Delmas C (1995) In vitro activity of RU 004 against Haemophilus influenzae and Moraxella catarrhalis. In Program and Abstracts of the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy. Washington, DC: American Society for Microbiology, abst F161, p. 141.
8. Ednie LM, Spangler SK, Jacobs MR, Appelbaum PC (1996) Activity of the ketolide RU 004 compared to 15 other agents against 228 erythromycin susceptible and resistant pneumococci. In Program and Abstracts of the 3rd International Conference of the Macrolides, Azalides, and Streptogramins, Lisbon, Portugal, abst 3.19, p. 32.
9. Fabre R, Cavallo JD, Chapalain JC, Meyran M (1995) Comparative in vitro activity of RU 004 against Neisseria gonorrhoeae and Neisseria meningitidis. In Program and Abstracts of the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy. Washington DC: American Society for Microbiology, abst F164, p. 141.
10. Fremaux A, Sissia G, Chantot JF, Geslom P (1995) Antibacterial activity of the ketolide RU 004 against multiresistant pneumococci. In Program and Abstracts of the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy. Washington, DC: American Society for Microbiology, abst F160, p. 141.
11. Leclerq R, Courvalin P (1991) Bacterial resistance to macrolide, lincosamide, and streptogramin antibiotics by target modification. Antimicrob Agents Chemother 35:1267-1272.
12. National Committee of Clinical Laboratory Standards (NCCLS) (1993a) Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically: approved standard M7-A3. 3rd edition. Villanova, PA: NCCLS.
13. National Committee for Clinical Laboratory Standards (NCCLS) (1993b) Methods for antimicrobial susceptibility testing of anaerobic bacteria: approved standard M11-A3. 3rd edition. Villanova, PA: NCCLS.
14. National Committee for Clinical Laboratory Standards (NCCLS) (1995) Performance standards for antimicrobial susceptibility testing: 6th informational supplement, M100-S6. Villanova, PA: NCCLS.
15. Rajagopalan-Levasseur P, Vallee E, Agouridas C, Chantot JF, Pocidalo JJ (1995) RU 004: Activity against erythromycin-resistant pneumococci and Haemophilus influenzae in murine pneumonia models. In Program and Abstracts of the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy. Washington, DC: American Society for Microbiology, abst F173, p. 143.
16. Vallee E, Azoulay-Dupuis E, Rajapopalan-Levasseur P, Agouridas C, Chantot JF, Pocidalo JJ (1995) Ketolides: Screening using relevant in vivo models of erythromycin-resistant pneumococcal infection. In Program and Abstracts of the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy. Washington, DC: American Society for Microbiology, abst F172, p. 143.